Roots Analysis

FEBRUARY 26, 2024

In fact, the share of biologics in the overall pharmaceutical contract manufacturing market has increased from 16% in 2006 to over 25% in 2017. Having reported over 70% increase in revenues over the past 5-6 years, the market for biologically derived products is currently estimated to be worth more than USD 200 billion.

Drug Delivery Systems 52

Drug Delivery Systems Drug Delivery Drugs Contract Manufacturing 52

Roots Analysis

MARCH 16, 2022

Presently, outsourcing of exosome related services has become a popular practice where drug developers are actively outsourcing their operations to specialized repurposed-based service providers, which are known to have the required capabilities and expertise. Exosome Service Providers – Current Market Landscape. Web: [link].

Marketing 59

Marketing Manufacturing Drug Delivery Drug Delivery Systems 59

Roots Analysis

MARCH 21, 2022

Subcutaneous biologics – current market landscape. Subcutaneous drug delivery systems – the helping hand for patients. There has been a significant increase in the number of biologics, specifically the new generation molecules, such as monoclonal antibodies, in the late-stage clinical studies ( phase II / phase III ).

Drug Delivery Systems 52

Drug Delivery Systems Drug Delivery Antibody Marketing 52

Roots Analysis

FEBRUARY 26, 2024

To learn more, please click New Frontiers Cancer Therapy market report. Types of Molecules and Regions Worldwide Overall, the growth is anticipated to be spread across multiple type of molecules and different geographical regions. For any queries / suggestions, please do not hesitate to contact us at sales@rootsanalysis.com.

Drug Delivery Systems 52

Drug Delivery Systems Marketing Drug Delivery Development 52

Roots Analysis

MARCH 3, 2022

Since the approval of Soliris® in 2007, an anti-C5 antibody, the field of complement drug discovery has gained significant attention. Next Generation Complement Therapeutics – Current Market Landscape. The market is characterized by a mix of well-established and small firms. Next Generation Complement Therapeutics Market.

Drug Delivery Systems 52

Drug Delivery Systems Marketing Immune Response Dermatology 52

Roots Analysis

MARCH 13, 2022

In the last decade alone, the annual number of approvals of biopharmaceuticals (including monoclonal antibodies, recombinant proteins, vaccines and gene therapies), by the US FDA, have steadily risen. Future Evolution of Biopharmaceutical Excipient Manufacturing Market. Our Social Media Platform. Web: [link]. LinkedIn: [link].

Manufacturing 52

Manufacturing Drug Delivery Marketing Drug Delivery Systems 52

Roots Analysis

FEBRUARY 14, 2023

This can be attributed to the fact that liposomes can actively target tumor tissues when used in combination with antibodies. Majority of the articles (51%) are focused on evaluating liposomes for use in cancer therapy. These platforms have created an opportunity for the product developers to share their innovative ideas in this domain.

Development 52

Development Manufacturing Drug Delivery Systems Contract Manufacturing 52